NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.
- DOI
- 10.1016/j.drup.2026.101436
- Published
- 2026 Sep
- Container
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drup.2026.101436,
title = {NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.},
author = {Chen L and Cheng F and Huang YH and Wang Y and He J and Liu J and Wang Z and Lin P and Fan Y and Bao L and Yi Q and Yang J},
year = {2026},
journal = {Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy},
doi = {10.1016/j.drup.2026.101436},
url = {https://doi.org/10.1016/j.drup.2026.101436}
}RIS
TY - JOUR TI - NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma. AU - Chen L AU - Cheng F AU - Huang YH AU - Wang Y AU - He J AU - Liu J AU - Wang Z AU - Lin P AU - Fan Y AU - Bao L AU - Yi Q AU - Yang J PY - 2026 JO - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy DO - 10.1016/j.drup.2026.101436 UR - https://doi.org/10.1016/j.drup.2026.101436 ER -
APA
L, C., F, C., YH, H., Y, W., J, H., J, L., Z, W., P, L., Y, F., L, B., Q, Y., & J, Y. (2026). NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. https://doi.org/10.1016/j.drup.2026.101436
Source records
- pubmed · retrieved 2026-09-25T18:06:20.892Z